InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Brenner Randall B., Executive. Director active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 14 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €68k. History available since 27 May 2021. The latest transaction was filed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
329,709 sharesCommon StockSEC:0000899243-23-019365:0
67,500 shares0Common StockSEC:0000904454-23-000478:0
15,000 shares0Common StockSEC:0000904454-22-000649:0
▼
11,105 shares@ US$1.9830.7% of flowCommon StockSEC:0000904454-22-000623:0
▼
3,516 shares@ US$3.4718.0% of flowCommon StockSEC:0000904454-22-000528:0
8,500 shares0Common StockSEC:0000904454-22-000506:0
47,727 shares0Common StockSEC:0000904454-22-000425:0
67,500 shares0Common StockSEC:0000904454-22-000264:0
▼
4,479 shares@ US$4.4250.0% of flowCommon StockSEC:0000904454-21-000844:0
▼
4,479 shares@ US$4.4225.7% of flowCommon StockSEC:0000904454-21-000844
21,250 shares0Common StockSEC:0000904454-21-000624:0
21,250 shares0Common StockSEC:0000904454-21-000624
28,636 shares0Common StockSEC:0000904454-21-000516
28,636 shares0Common StockSEC:0000904454-21-000516:0
14 of 14 declarations
About Brenner Randall B.
Randall B. Brenner is associated with Paratek Pharmaceuticals, Inc. Although his specific role is not detailed, he contributes to the leadership and strategy of the company. Brenner is involved in initiatives that support the company's objectives in the pharmaceutical sector.
